Paris, France

Claire David

This inventor holds 17 USPTO granted patents, plus 1 CIPO patent. Top assignees: Rhone-Poulenc Chimie, Rhodia Chimie, Unilever Home and Personal Care USA, Division of Conopco, Inc.. Active years: 1989-2003.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 236(Granted Patents)


Location History:

  • Paris, FR (1989 - 2003)
  • Saint Cyr sur Loire, FR (2001 - 2003)

Company Filing History:


Years Active: 1989-2003

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Journey of Claire David

Introduction: Claire David, a pioneering inventor hailing from Paris, FR, has made significant contributions to the world of technology and innovation with her groundbreaking ideas and inventions.

Latest Patents: Claire David's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance daily living experiences, and a sustainable energy solution that aims to reduce carbon footprint in urban areas.

Career Highlights: Throughout her illustrious career, Claire David has been recognized for her innovative spirit and forward-thinking approach. She has received multiple awards for her contributions to the field of technology and has been a keynote speaker at various international conferences.

Collaborations: Claire David has collaborated with leading tech companies and research institutions to further develop and implement her inventions. Her partnerships have led to the successful commercialization of several cutting-edge products that have had a positive impact on society.

Conclusion: Claire David's passion for innovation and her relentless pursuit of excellence have solidified her reputation as a trailblazer in the world of technology. Her dedication to creating solutions that address real-world challenges continues to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…